Angiotech Pharmaceuticals

Medtech · Acquired

Paclitaxel drug-eluting stent coatings and surgical specialty product formulations

angiotech.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
22
0 granted · 22 pending
Sector median: 2

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1025Windgap Medical, Inc.—$41M
1026Greenwings Biomedical, Inc.——
1027Spheryx, Inc.—$1.7M
1028Angiotech Pharmaceuticals——
1029FERRIC CONTRAST, INC.——
1030ALIENBYTE Scientific Software Inc——
1031Limber Prosthetics, Inc.—$3.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 22
  • Compositions And Methods For Coating Medical Implantsapplication
  • Self-retaining Variable Loop Suturesapplication
  • Surface Texture Configuration For Self-retaining Sutures And Methods For Forming Sameapplication
  • Self-retaining Systems Having Laser-cut Retainersapplication
  • Laser Cutting System And Methods For Creating Self-retaining Suturesapplication
  • Bidirectional Self-retaining Sutures With Laser-marked And/or Non-laser Marked Indicia And Methodsapplication
  • Braided Self-retaining Sutures And Methodsapplication
  • Length Of Self-retaining Suture And Method And Device For Using The Sameapplication
  • Coded Heterofunctional Sutures And Methodsapplication
  • Shape-memory Self-retaining Sutures, Methods Of Manufacture, And Methods Of Useapplication
  • Biocompatible Crosslinked Hydrogels, Drug-loaded Hydrogels And Methods Of Using The Sameapplication
  • Self-retaining Sutures With Bi-directional Retainers Or Uni-directional Retainersapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.